An innovative new injectable injectable skin treatment targeting skin laxity is about to land on the Australian Medical Aesthetic market in September, and we are excited!

By 2020 some 1.5 million treatments had been performed worldwide with evidence supporting its excellent safety profile and multiple award-winning status, and it has already taken the UK and New Zealand by storm.

Classed as a ‘bio-remodeller’ , this medical product (we can’t advertise the name due to TGA guidelines) improves skin laxity and elasticity to renew your skin from within. It stimulates production of your natural collagen and elastin to prevent lines, wrinkles and optimise skin health and hydration.